Significant increase risk of lung cancer with Arg/Pro genotype of TP53, Lys/Gln and Gln/Gln variants of XPD was found in individuals with a family history of cancer (Table 3), which revealed that family history of cancer may be a risk factor for patients having these gene variants. This evidence concerns the gene ERCC2 and lung carcinoma.